Excellent
Mostly Aligned
Patient Risk:
Low
Summary
The claim matches the FDA-approved indication wording in the provided label excerpt (persistent facial erythema associated with rosacea in adults) and accurately identifies Rhofade as a prescription medicine.
Category Scores
Accurate Statements
Rhofade is a prescription medicine used to treat persistent facial redness (erythema) due to rosacea in adults.
1 INDICATIONS AND USAGE: “RHOFADE (oxymetazoline hydrochloride) cream, 1% is indicated for the topical treatment of persistent facial erythema associated with rosacea in adults.”
Unsupported Statements
Rhofade is a prescription medicine
The provided label excerpts do not explicitly state that Rhofade is prescription-only; however, the rest of the statement aligns with the indication text.
Contradictions
Important Omissions
Route of administration (topical) and the product being a cream were not specified in the claim.
Importance:
Low
Safety Assessment
Potential Patient Risk:
Low
The claim accurately reflects the indicated condition and adult population; it does not include dosage, contraindications, warnings, or interaction statements that could materially affect safe use.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Prescription status and topical/cream route details are not explicitly stated in the claim (though the indication content is correct).
Suggested Improvement
Include wording such as “topical treatment” and/or “cream” to more closely track the label.